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The Ecballium elaterium trypsin inhibitor II (EETI-II)
belongs to the family of squash inhibitors and is one of the
strongest inhibitors known for trypsin. The eight independent
molecules of EETI-II in the crystal structure reported here
provide a good opportunity to test the hypothesis that this
small cystine-knot protein (knottin) is sufficiently rigid to be
used as a molecular scaffold for protein-engineering purposes.
To extend this test, the structures of two complexes of EETI-II
with trypsin have also been determined, one carrying a four-
amino-acid mutation of EETI-II. The remarkable similarity of
these structures confirms the rigidity of the molecular
framework and hence its suitability as a molecular scaffold.
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PDB References: EETI-II,
1w7z, r1w7zsf; trypsin–
EETI-II (wild type) complex,
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1. Introduction
Rigid molecular ‘scaffolds’ are much sought after for protein
engineering: they should enable the de novo design of proteins
with specific properties without the complications introduced
by conformational flexibility and the protein-folding problem
(Skerra, 2000). Promising candidates for rigid molecular
scaffolds include knottins (Le-Nguyen et al., 1990), small
proteins that share a common structural motif consisting of a
cystine knot and a small triple-stranded antiparallel -sheet.
The lack of a hydrophobic core to provide structural stability
is compensated by three disulfide bridges between the first and
fourth, second and fifth, and third and sixth cysteines in the
sequence. The first two disulfide bridges hold the polypeptide
chain in a ring through which the third one passes (Fig. 1). This
‘cystine knot’ is found in a variety of small proteins from
diverse organisms, and members of this family display diverse
biological functionalities, mainly acting as inhibitors (Pallaghy
et al., 1994; Craik et al., 2001). Examples of micro-proteins
sharing this architecture are (i) !-conotoxin MVIIa from the
venom of the cone snail Conus magus, a 26-residue neurotoxin
with a high affinity for voltage-gated Ca2+ channels (Kohno et
al., 1995), (ii) potato carboxypeptidase inhibitor (PCI), a 39-
amino-acid peptide (Rees & Lipscomb, 1982), (iii) EETI-II
from the jumping cucumber Ecballium elaterium, a 28-amino-
acid member of the squash family of proteinase inhibitors
(Favel et al., 1989; Heitz et al., 1989; Le-Nguyen et al., 1990,
1993) and (iv) the cyclic 29-amino-acid inhibitor kalata B1
(Saether et al., 1995).
Some members of the inhibitor cystine-knot family are
extremely stable towards heat, digestion by proteases or
denaturation by chaotropic agents. Recently, a systematic
study on the thermal, chemical and enzymatic stability of
cyclotide kalata B1 and variants was published (Colgrave &
Craik, 2004). It was shown that kalata B1 variants maintained
their structural stability when subjected to heat, acids or
chaotropic agents, even for acyclic mutants. In contrast,
structural integrity was lost on guanidinium chloride treat-
ment of a mutant with the first cystine changed to alanines,
thereby undoing the cystine knot. The thermal stability of
conotoxin PVIIA, also a cystine-knot protein, was found to be
much lower than that of kalata B1. This result showed that
also other structural features such as the strong hydrogen-
bonding network of kalata B1 contribute to the overall
stability of cystine-knot proteins. The thermal, chemical and
enzymatic stability of kalata B1 might also be an indication of
structural rigidity.
Biochemical assays by Christmann et al. (1999) have
suggested that the cystine-knot protein EETI-II is indeed
sufficiently rigid to be useful as a molecular scaffold for the
presentation of combinatorial peptide libraries. EETI-II is one
of the strongest inhibitors known for trypsin (binding constant
Ka = 8  1011 M1; Favel et al., 1989) and folds spontaneously
in vitro with proper formation of cystine bonds (Wentzel et al.,
1999). The fortuitous presence of eight independent molecules
of recombinant EETI-II in the crystal structure reported here
provides a good test of its conformational rigidity. We have
also determined the structures of two of its complexes with
trypsin for a further test of the conformational invariance. The
sequences of the EETI-II variants used in this study are shown
in Fig. 1. The variant EETI-II-GPNG is also considered as a
wild type. A preliminary communication concerning the
crystallization and diffraction properties of porcine trypsin in
complex with EETI-II was published 16 years ago (Gaboriaud
et al., 1989), but no results of a structural analysis have been
published or deposited to date.
2. Materials and methods
2.1. Crystallization
Unless otherwise stated, chemicals were purchased from
Fluka. Porcine trypsin (EC 3.4.21.4) was obtained from Sigma,
Deisenhofen. Recombinant EETI-II wild type and variants
were obtained by genetic engineering techniques as previously
described (Wentzel et al., 1999).
Uncomplexed EETI-II (wt) was crystallized at 277 K using
the hanging-drop vapour-diffusion technique (McPherson,
1998). Extremely hygroscopic crystals (0.08  0.05 
0.05 mm) could be obtained from droplets containing 1.5 ml
protein solution (40 mg ml1 EETI-II in double-distilled
water) and 1.5 ml precipitant (4M sodium formate) within
several days.
Porcine trypsin was complexed with EETI-II in a molar
ratio of 1:1.2. Complexation was performed in 100 mM bicine
pH 8.0 for wild-type EETI-II and in 50 mM triethanolamine–
HCl buffer pH 7.4 for the variants, using a total protein
concentration of 10 mg ml1. Crystallization of the complexes
was achieved by the hanging-drop vapour-diffusion method at
293 K. The drop was prepared by mixing equal volumes of the
buffered complex solution and the reservoir solution, which
contained 100 mM sodium citrate buffer pH 5.3, 20%(v/v)
2-propanol and 20%(w/v) polyethylene glycol 4000 for the
wild-type complex, and 100 mM sodium citrate buffer pH 5.3,
100 mM triethanolamine–HCl buffer pH 7.4, 20%(v/v)
2-propanol and 20%(w/v) polyethylene glycol 4000 for the
variants. Single crystals suitable for X-ray analysis grew within
a few days. The crystals of the wild-type complex were octa-
hedral with a maximum dimension of 0.25 mm; the trypsin–
EETI-II-TNNK and trypsin–EETI-II-NEDE complexes gave
rod-like crystals with a maximum size of 0.4  0.1  0.05 mm.
2.2. Data collection and processing
Native diffraction data were collected at beamline BL2 at
BESSY in Berlin with a MAR345 image-plate detector using
2M sodium malonate as cryoprotectant. Diffraction data for
the trypsin–EETI-II-GPNG (wild type) complex were
collected on beamline ID14-EH2 at ESRF, Grenoble using a
cryoprotectant buffer composed of the reservoir solution plus
5% glycerol. Crystals of the remaining two complexes were
mounted in sealed glass capillaries and data were collected at
room temperature to 1.9 and 3.0 A˚, respectively, with a
MAR345 detector on a Siemens rotating-anode X-ray
generator with Cu K radiation and Osmic mirrors. Data were
processed with DENZO and SCALEPACK (Otwinowski &
Minor, 1997). The 3.0 A˚ data of the trypsin–EETI-II-NEDE
complex were not analyzed further after we had established
that the structure was isomorphous with that of the 1.9 A˚
trypsin–EETI-II-TNNK complex. Data quality and refinement
statistics are summarized in Table 1.
2.3. Structure solution
All three structures were solved by molecular replacement.
Porcine trypsin (Stubbs et al., 1997; PDB code 1ldt) was used
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Figure 1
The cystine-knot motif in EETI-II and the sequences of the proteins
investigated in this study. The sequence of EETI-II isolated from seeds of
jumping cucumber E. elaterium was C-terminally extended by amino
acids SPHHHHHH for affinity chromatography. The mutation M7I was
introduced for purification purposes. Sequence deviations compared with
the sequence of native EETI-II are highlighted in grey.
as a search model for the complexes and the EETI-II model
from the wild-type complex was then used to solve the native
wild type. The structure of the trypsin–EETI-II-GPNG (wild
type) complex was solved with AMoRe (Navaza, 1994) using
data between 7 and 3.5 A˚ (other resolution ranges gave
slightly poorer results). The best solution was identified by a
correlation coefficient of 50.5% and a crystallographic R
factor of 45.5%, which were well separated from the values of
23.4 and 54.7% for the next solution. The trypsin–EETI-II-
TNNK complex was solved with EPMR (Kissinger et al., 1999)
using data between 15 and 4 A˚. The
correct solution was identified by a
correlation coefficient of 64.8% and an
R factor of 36.7%. After attempts with
other programs had not been successful,
six of the final eight molecules in the
asymmetric unit of the native EETI-II
could be located using PHASER (Read,
2001) with default settings. A-weighted
electron-density maps (Read, 1986)
calculated from these six molecules
indicated the presence of two additional
molecules that could be fitted to the
density by hand. The estimated
Matthews coefficients (mc) and solvent
contents (sc) for the reported
structures were as follows: EETI-II wt,
mc = 2.6 A˚3 Da1, sc = 52.6%; trypsin–
EETI-II-GPNG, mc = 2.7 A˚3 Da1, sc =
54.5%; trypsin–EETI-II-TNNK, mc =
3.0 A˚3 Da1, sc = 58.9%.
2.4. Structure refinement
The uncomplexed structure
consisting of eight EETI-II molecules
was refined with REFMAC5
(Murshudov et al., 1997) against F; NCS
restraints were not used. The complex
structures were refined with SHELXL
(Sheldrick & Schneider, 1997) against
F 2. In both cases, 5% of the data were
flagged for Rfree (Bru¨nger, 1993) and
2mFo  DFc and Fo  Fc maps were
displayed with XFIT (McRee, 1999),
which was also used for manual
rebuilding of the structure and identi-
fying disordered components. A bond-
valence calculation for the three cations
in the uncomplexed structure, using the
methods of Mu¨ller et al. (2003),
favoured Ca2+ and would also allow
Na+, but was not consistent with NHþ4
(which would have accounted for the
approximately tetrahedral coordination
but had a bond-valence sum that was a
factor of about four too high). Since the
crystals were grown from 4M sodium formate and neither
Ca2+ nor NHþ4 should have been present, these three ions were
refined as sodium, which resulted in temperature factors
similar to those of the surrounding atoms. The three V-shaped
solvent particles were refined as formate ions, balancing the
charge. In the complexes, omit maps were employed to
establish the structure of the -turn for residues 22–25 in
EETI-II. As usual, the trypsin complexes included a Ca2+ ion.
The quality of the final structures was assessed with
PROCHECK (Laskowski et al., 1993). Figures were drawn
research papers
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Table 1
Data-collection and refinement statistics for EETI-II and trypsin–EETI-II complexes.
Values in parentheses are for the outer resolution shell.
EETI-II-GPNG
Trypsin–
EETI-II-GPNG
Trypsin–
EETI-II-TNNK
Space group C2 P4132 I4
Unit-cell parameters (A˚, ) a = 71.16, b = 82.34,
c = 62.93,  = 118.8
a = b = c = 121.05 a = b = 139.86,
c = 33.67
Temperature of data collection (K) 100 100 293
Resolution (A˚) 1.68 (1.68–1.80) 1.5 (1.5–1.6) 1.9 (1.9–2.0)
Unique reflections 35516 49533 26024
Completeness (%) 96.8 (99.0) 99.7 (99.6) 99.1 (97.9)
Mean redundancy 4.42 8.05 6.60
Rsym (%) 6.9 (44.0) 5.3 (39.6) 6.8 (21.7)
Average I/(I) 13.7 (3.1) 19.2 (3.8) 17.8 (8. 9)
Protein atoms 1890 1861 1883
Solvent atoms 132 177 135
Mean e.s.d. in atom position† (A˚) 0.16 0.12 0.15
R.m.s. bond-length deviation (A˚) 0.020 0.009 0.007
R.m.s. bond-angle deviation () 1.8 1.2 1.1
Mean B value of main-chain atoms (A˚2) 31.1 31.1 21.5
Mean B value of side-chain atoms (A˚2) 32.8 34.4 24.8
Mean B value of solvent atoms (A˚2) 37.5 44.9 38.7
Ramachandran most favoured regions (%) 95.5 89.5 90.1
Ramachandran allowed regions (%) 100.0 100.0 100.0
Rwork‡ (%) 19.5 21.1 13.6
Rfree‡ 23.5 25.4 17.0
PDB code 1w7z 1h9h 1h9i
† Calculated using the DPI formula from Cruickshank (1999). ‡ Rsym =
P jIhkl  hIhklij=
P
Ihkl . † Rfree =PjFobsj  jFcalcj

=
P jFobsj for the 5% of reflections in the test set; Rwork is calculated in the same way for the
remaining reflections.
Figure 2
Stereoview of the overall structure of the uncomplexed EETI-II. Sodium ions are represented as
solid balls and formate ions as sticks. Hydrophobic residues participating in the A–F hexamer
formation are highlighted using darker colours.
with MOLSCRIPT (Kraulis, 1991), BOBSCRIPT (Esnouf,
1997) and RASTER3D (Merritt & Bacon, 1997).
3. Results and discussion
The EETI-II molecules adopt the canonical conformation of
the cystine-knot inhibitor family. The core of the molecule is
made up by a three-stranded antiparallel -sheet consisting of
-strands spanning over the peptide stretches 6–8, 20–22 and
26–28 (Fig. 1). These are connected by short coils, of which the
second is interrupted by a four-residue 310-helix. The EETI-II
variants used in this study differ from the wild-type protein in
as much as they all contain the mutation Met7Ile and a
C-terminal extension with the amino-acid sequence
SPHHHHHH, both of which were introduced to simplify the
preparation and purification procedure (Wentzel et al., 1999).
The six-histidine tag was not visible in the electron density in
any of these structures. Although this is the normal state of
affairs in the many crystal structures that have been reported
of proteins containing such tags, the implicit assumption that
the tags behave as disordered solvent and have little structural
influence is a matter of some concern. As we show later, the
CMTI-I structure that did not contain this tag is very similar to
that of EETI-II.
3.1. The wild-type structure
As shown in Fig. 2, the eight molecules in the asymmetric
unit of the uncomplexed EETI-II (referred to as molecules
A–H) form a 6+2-type octamer in such a way that six mole-
cules (A–F) associate into a hexamer, whereas molecules G
and H are attached to this hexamer in a rather irregular
fashion. The structure of the hexamer can be visualized as
follows. Molecule pairs AB, CD and EF form dimers with
twofold non-crystallographic symmetry between the mole-
cules. This molecular association is mediated by three metal
ions refined as sodium ions (Fig. 3) that are coordinated by the
main-chain O atoms of residues Ser13 and Cys15 of both
molecules with an average sodium–oxygen distance of 2.22 A˚.
The dimerization is also promoted by hydrophobic contacts
between Leu16 side chains from both monomers that are at an
average minimum distance of 3.74 A˚ apart. These six mole-
cules further associate into a hexamer so that a threefold non-
crystallographic axis relates molecules A, C and E. Molecules
B, D and F are also arranged as a quasi-trimer but are
translated by about 12 A˚ along the same axis. The hexamer is
held together by hydrophobic forces. Water-repulsive side
chains of residues Pro3, Ile5, Leu6, Ile7 and Leu16 of mole-
cules A–F form the hydrophobic core of the hexamer, where a
water-excluded volume of about 4 A˚ diameter can be located.
The three formate ions attached to molecules B, D and F
neutralize the charge of the three Arg8 residues and can be
located at the interface between the hexamer and the mole-
cules G and H.
In contrast to molecules A–F, G and H are bound to the
hexamer predominantly via hydrophilic interactions. Residues
Arg8(B) and Arg8(F) are within hydrogen-bonding distance
of the main-chain O atom of Gly1(G), Arg4(G) and Ala17(G),
and hydrogen bonds were found between the side-chain N
atom of Lys10(H) and the main-chain O atom of Cys21(D).
The interactions between atom pairs Cys9(H)—O  H2N—
Arg4(B) and Cys9(H)—O  O—Cys9(D) are mediated by a
water molecule. Molecules G and H occupy a relative position
to each other that was observed in the case of molecules of the
hexamer but are further apart and therefore lack any G–H
intermolecular interactions; a sodium ion typical of molecules
A–F could not be found between these molecules either.
Comparison of the average temperature factors of all
molecules in the asymmetric unit revealed a correlation
between the thermal motion and the position of the molecule
research papers
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Figure 3
Dimer formed by the molecules A and B. Molecule pairs CD and EF
display a similar arrangement. The sodium ion is shown as a solid ball.
Figure 4
The consequences of radiation damage (wild-type complex). (a) A
A-weighted difference map shows negative density (red) at the disulfide
bridge and positive density (green) consistent with an extra atom
attached to C of Cys7 in trypsin; (b) the interpretation as a partially
occupied disulfide bridge and a partially occupied serine instead of Cys7.
The contouring levels for the density maps were 1 (A map) and 3 for
the difference density map.
within the octamer, as molecules A–F possess significantly
lower B values than G and H (29.0 and 37.2 A˚2 for molecules
A–F and G–H, respectively). This finding can be explained by
the higher number of intermolecular interactions observed in
the hexamer and by the lack of the sodium ion that would
promote the dimerization of molecules G and H. This also
explains the difficulties in locating molecules G and H by
molecular replacement.
3.2. Trypsin complexes of EETI-II
Porcine trypsin was co-crystallized with three different
sequences for the -turn of EETI-II involving residues 22–25:
GPNG (the wild-type sequence), TNNK and NEDE, yielding
cubic crystals in space group P4132 for the former sequence
and tetragonal crystals in space group I4 for the latter two.
These two mutants were selected for crystallization and
structural investigation because they show different behaviour
in folding-kinetics studies to that of wild-type EETI-II
(Wentzel et al., 1999). Since the NEDE complex was
isostructural with that of the TNNK mutant and diffracted to
lower resolution (3.0 A˚ in-house), it was not investigated
further.
The main chain of the inhibitor is well defined in electron-
density maps from Gly1 to Pro30 (the start of the His tag).
Owing to the high intensity of the synchrotron beam used for
the cubic crystals (ID14-EH2 at ESRF, Grenoble) some
radiation damage is apparent in this structure (Fig. 4). Some of
the disulfide cysteines in the trypsin molecule were modelled
as partially oxidized to serine, in accordance with high-
resolution studies of radiation damage (Burmeister, 2000;
Weik et al., 2000). For Cys128 no density was present for S.
The main chain in this area (residues 127–132) has an average
B value of 36.4 A˚2 and is poorly defined. This indicates the
cleavage of the disulfide bridge Cys128–Cys232 which other-
wise would constrain this loop. Also, the C-terminal -helix
(Val235–Asn245) shows somewhat high main-chain B values
(mean 36.4 A˚2) and residual difference electron-density peaks,
indicating some disorder.
Fig. 5 shows the different packing in the two structures. In
the cubic form the GPNG -turn is involved in packing
contacts with its symmetry equivalents, but in the tetragonal
form the EETI-II mutants are located in the interior of wide
solvent-filled channels, with the -turn exposed to the solvent.
There are 18 polar and 14 non-polar short interatomic inter-
actions between the EETI-II inhibitor loop, Cys2–Leu6, and
the trypsin molecule, consistent with the very high binding
constant (Ka = 8  1011 M–1; Favel et al., 1989).
3.3. Comparison of the various EETI-II structures
Least-squares superposition of all main-chain atoms in the
eight crystallographically independent molecules in the
uncomplexed EETI-II structure gives r.m.s.d.s (root-mean-
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Table 2
R.m.s.d.s (A˚) between the eight independent EETI-II molecules A–H in
the wild-type structure and between A–H and the two complexes, the
crystal structure of the related sequence 1luo and the NMR structure of
EETI-II 2eti.
A B C D E F G H
B 0.39
C 0.33 0.25
D 0.33 0.37 0.32
E 0.32 0.33 0.25 0.42
F 0.35 0.32 0.28 0.31 0.35
G 0.58 0.60 0.54 0.52 0.54 0.51
H 0.51 0.61 0.62 0.44 0.70 0.57 0.54
Trypsin–EETI-II-GPNG 0.49 0.53 0.45 0.40 0.57 0.49 0.53 0.43
Trypsin–EETI-II-TNNK 0.55 0.59 0.51 0.51 0.63 0.59 0.59 0.48
1lu0 0.81 0.87 0.86 0.73 0.96 0.86 0.74 0.66
2eti 2.12 2.07 2.10 2.18 1.88 2.07 2.02 2.20
Figure 5
Packing of the trypsin–EETI-II complexes. (a) The cubic crystal form of the wild-type complex; (b) the tetragonal crystal form of the EETI-II–TNNK
complex.
square deviations) in the range 0.25 A˚ (molecules C and E) to
0.70 A˚ (E and H). Molecules A–F differ from each other to a
lesser extent than from molecules G and H (Table 2). These
deviations are significantly larger than the mean coordinate
errors (Table 1), which are in the range 0.12–0.16 A˚. The
program ESCET (Schneider, 2002) was used to establish
which regions of the protein molecule are flexible and which
parts can be regarded as a rigid framework. As illustrated in
Figs. 6(a) and 7(a), short regions around
positions 4 and 24 were found to be some-
what flexible, but the rest of the molecule
seems to be rather rigid. The structural
flexibilty of EETI-II at residue 4 between
the complexed and uncomplexed inhibitor
molecules can be explained by strong
binding of Arg4 to Asp189 in the trypsin
catalytic site.
A similar result was obtained on super-
imposing the uncomplexed EETI-II struc-
tures and the wild-type EETI-II–trypsin
complex (Fig. 6b). In this case, the mean
r.m.s.d. varies between 0.40 A˚ (moleculeD)
and 0.57 A˚ (molecule E). Significant side-
chain reorientations were observed, mostly
in the Arg4–Arg8 and the Asn24–Phe26
regions, owing to different intermolecular
interactions. For instance, in the complex
the EETI-II residue Arg4 is involved in a
salt bridge to the trypsin Asp189, whereas
Arg8 forms hydrogen bonds to His40 and
Ser39 through a water molecule. Since the
uncomplexed EETI-II lacks those inter-
actions, these side chains are free to adopt
different conformations. Similarly, Ile5 and
Leu6 take part in hydrophobic inter-
molecular interactions in the uncomplexed
structure that are not possible in the
complex, leading to different side-chain
conformations.
Comparison with the NMR model of
EETI-II (Chiche et al., 1989; PDB code
2eti) revealed striking differences even in
the main-chain conformation of the mole-
cules (mean r.m.s.d. 2.08 A˚). Large varia-
tions in the torsion angles could be
observed in regions 1–7, 11–15 and 21–26 as
illustrated in Fig. 6(b). In particular, the
large difference between the conformation
of the inhibitor-binding loop of the NMR
and all the X-ray structures, despite the fact
that according to the X-ray structures it
scarcely changes on complex formation, is
difficult to explain. In contrast to all the
X-ray EETI-II structures, which have about
90% of residues in the most favoured
regions and 100% in the allowed regions of
the Ramachandran plot (calculated using
PROCHECK; Laskowski et al., 1993), the
deposited NMR structure (2eti) has only
62% in the most favoured regions and 90%
in the allowed regions.
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Figure 6
Least-squares superpositions of all main-chain atoms of EETI-II. (a) All eight independent
molecules in the uncomplexed structure; (b) uncomplexed (black) and complexed (red)
EETI-II and the NMR model (green); (c) uncomplexed EETI-II (black), the trypsin–EETI-II-
TNNK complex (red) and CMTI-I (blue).
The superposition of the averaged structure of the eight
independent uncomplexed EETI-II molecules with the EETI-
II-TNNK mutant in complex with trypsin and with the related
inhibitor CMTI-I (Thaimattam et al., 2002; PDB code 1lu0)
shown in Fig. 6(c) highlights similar small variations as in the
comparison of the complexed and uncomplexed wild-type
molecules, with some additional variation around position 17.
The mean r.m.s.d.s are 0.48 and 0.81 A˚, respectively. It is
worthy of note that these regions also show the largest thermal
motion (Fig. 7b) and are the least conserved parts of the
sequence (Fig. 7c based on 30 EETI-II-related sequences; see
also Leluk, 2000), i.e. the higher conformational flexibility is
coupled with larger variability of the sequence.
4. Conclusions
The remarkable similarity of the structures of all nine crys-
tallographically characterized molecules with the EETI-II-
GPNG sequence and the close similarity with one mutant and
with the previously reported CMTI-I (Thaimattam et al.,
2002), despite different molecular environments in the native
and complexed forms, provide convincing evidence that
EETI-II is a rather rigid molecule, making it a suitable choice
for a molecular scaffold.
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